Zhi Jian Chen
Director/Board Member at Shanghai Haihe Biopharma Co., Ltd.
Zhi Jian Chen active positions
| Companies | Position | Start | End |
|---|---|---|---|
Shanghai Haihe Biopharma Co., Ltd.
 Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Director/Board Member | 01/01/2018 | - |
Huatai Futures Co., Ltd.
 Huatai Futures Co., Ltd. Investment ManagersFinance Part of Huatai Securities Co., Ltd., Huatai Futures Co., Ltd. provides investment brokerage and asset management services. The company is based in Guangzhou, China. The Chinese company was founded in 1994. The CEO is Chang Tao Zhao. | Director/Board Member | 28/12/2010 | - |
Career history of Zhi Jian Chen
Former positions of Zhi Jian Chen
| Companies | Position | Start | End |
|---|---|---|---|
| DELUXE FAMILY CO., LTD. | Director/Board Member | 23/08/2010 | 31/05/2012 |
| General Counsel | 23/08/2010 | 31/05/2012 | |
| Shanghai Nanjiang Group Co. Ltd. /Old/ | Director/Board Member | 06/01/2012 | 06/01/2012 |
Statistics
International
| China | 5 |
Operational
| Director/Board Member | 4 |
| General Counsel | 1 |
Sectoral
| Finance | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| DELUXE FAMILY CO., LTD. | Finance |
| Private companies | 3 |
|---|---|
| Shanghai Nanjiang Group Co. Ltd. /Old/ | Finance |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Commercial Services |
Huatai Futures Co., Ltd.
Huatai Futures Co., Ltd. Investment ManagersFinance Part of Huatai Securities Co., Ltd., Huatai Futures Co., Ltd. provides investment brokerage and asset management services. The company is based in Guangzhou, China. The Chinese company was founded in 1994. The CEO is Chang Tao Zhao. | Finance |
- Stock Market
- Insiders
- Zhi Jian Chen
- Experience
